Neurosalience Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $75K

  • Investors
  • 10

Neurosalience General Information

Description

Developer of a health technology platform intended for the early detection of dementia through medical imaging analysis. The company processes structural magnetic resonance imaging and computed tomography scan data, including low-resolution images, enabling healthcare providers to identify dementia-related conditions earlier and support patient care management.

Contact Information

Website
www.neurosalience.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 71-75 Shelton Street
  • Covent Garden
  • London WC2H 9JQ
  • England, United Kingdom
Primary Industry
Decision/Risk Analysis
Vertical(s)
LOHAS & Wellness, Digital Health, Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • 71-75 Shelton Street
  • Covent Garden
  • London WC2H 9JQ
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurosalience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Accelerator/Incubator 13-Apr-2023 $75K Completed Generating Revenue
7. Accelerator/Incubator 26-Oct-2021 Completed Generating Revenue
6. Accelerator/Incubator 13-Apr-2021 Completed Generating Revenue
5. Accelerator/Incubator 18-Mar-2021 Completed Generating Revenue
4. Accelerator/Incubator 16-Feb-2021 Completed Generating Revenue
3. Accelerator/Incubator 29-Jan-2021 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2021 $131K Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2020 $131K $131K Completed Startup
To view Neurosalience’s complete valuation and funding history, request access »

Neurosalience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neurosalience Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
EASME - EU Executive Agency for SMEs Corporation
European Innovation Council Accelerator/Incubator
EIT Health Accelerator/Incubator
Health Founders Accelerator/Incubator
PanaceaStars Accelerator/Incubator Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

Neurosalience FAQs

  • When was Neurosalience founded?

    Neurosalience was founded in 2020.

  • Where is Neurosalience headquartered?

    Neurosalience is headquartered in London, United Kingdom.

  • What is the size of Neurosalience?

    Neurosalience has 3 total employees.

  • What industry is Neurosalience in?

    Neurosalience’s primary industry is Decision/Risk Analysis.

  • Is Neurosalience a private or public company?

    Neurosalience is a Private company.

  • What is Neurosalience’s current revenue?

    The current revenue for Neurosalience is .

  • How much funding has Neurosalience raised over time?

    Neurosalience has raised $387K.

  • Who are Neurosalience’s investors?

    EASME - EU Executive Agency for SMEs, European Innovation Council, EIT Health, Health Founders, and PanaceaStars are 5 of 10 investors who have invested in Neurosalience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process